Cellosaurus HeLa-P4 (CVCL_E8AR)
Cell line name | HeLa-P4 | |
---|---|---|
Synonyms | HeLa P4; P4; HeLa-LTR-lacZ clone Z24 CD4 clone P4 | |
Accession | CVCL_E8AR | |
Resource Identification Initiative | To cite this cell line use: HeLa-P4 (RRID:CVCL_E8AR) | |
Comments | Population: African American. Characteristics: Expression of CD4 is under the control of a mouse PGK promoter (PubMed=7520946). Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (from parent cell line). Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4. Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ). Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo. Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. | |
Disease | Human papillomavirus-related endocervical adenocarcinoma (NCIt: C27677) | |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
Hierarchy | Parent: CVCL_E8AP (HeLa-LTR-lacZ clone Z24) Children:
| |
Sex of cell | Female | |
Age at sampling | 30Y6M | |
Category | Cancer cell line | |
Publications | PubMed=7520946; DOI=10.1006/jmbi.1994.1542 | |
Entry history | ||
Entry creation | 10-Apr-2025 | |
Last entry update | 10-Apr-2025 | |
Version number | 1 |